Clinical trials show progress in migraine frequency, skin cancer prevention
-
4:11
Wisconsin mother and daughter run 157 miles across Utah for MS...
-
4:10
Better Business Bureau warns of moving scams as busy season begins
-
2:24
Chance for storms returns after a warm Monday
-
1:07
Sunday kicks off Tick Awareness Week
-
0:44
Greenfield Farmer’s Market opens for 2026 season
-
0:53
Bikers gather on roadway for annual ’Biker’s Unity Peace...
-
2:22
New Jersey nonprofit flies recovered Ridglan Farm beagles to...
-
3:47
Seniors at Franklin memory care center create joy and new memories...
-
1:13
Nixon Park
-
3:01
A few fronts, a few shower chances early in the week
-
0:52
Milwaukee leaders host family resource fair, giving north side...
-
0:53
West Allis Farmers Market opens for 107th season
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.